• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TOSOH CORPORATION TOSOH HLC-723G8 ANALYZER G8

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TOSOH CORPORATION TOSOH HLC-723G8 ANALYZER G8 Back to Search Results
Model Number G8
Device Problem Device Operational Issue (2914)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/09/2018
Event Type  malfunction  
Manufacturer Narrative
A 13-month complaint history review and service history review for similar complaints was performed for serial number (b)(4) from 09-feb-2018 through aware date 09-mar-2018.There were five (5) similar complaints identified during the searched period.The g8 operator's manual under chapter 1, introduction and applications, states the following: the time from injection of the sample to the time the specific peak elutes off the column is called retention time.The tosoh automated glycohemoglobin analyzer hlc-723g8 software has been written so that each of the expected fractions has a window of acceptable retention times.If the designated peak falls within the expected window, the chromatogram peaks will be properly identified.When a peak elutes at a retention time not within a specified window, an unknown peak (p00) results.If more than one peak elutes at times not specified by the software windows, each is given a sequential p0x title.In order to keep the peaks within their appropriate windows, it may be necessary to change how fast or slow the buffers are moving through the system by changing the pump flow rate.The most probable cause of the fast retention time could not be determined.(b)(4).
 
Event Description
On (b)(6) 2018, a customer reported seeing fast retention time of 0.62 minutes (acceptable range is 0.57 to 0.61 minutes) with two (2) patient samples on the g8 instrument.The customer confirmed that the current retention time was within acceptable range; therefore, there was no need for flow factor adjustment.It is not known whether hemoglobin a1c results were impacted due to the out of range retention time.There is no indication of any patient intervention or adverse health consequences due to this event.
 
Manufacturer Narrative
Tosoh bioscience, inc.Is submitting on behalf of the foreign manufacturer, tosoh corporation, per exemption number e2017013.Submission of this report does not constitute an admission that the importer or manufacturer's product caused or contributed to the event.
 
Event Description
On (b)(6) 2018, a customer reported seeing fast retention time of 0.62 minutes (acceptable range is 0.57 to 0.61 minutes) with two (2) patient samples on the g8 instrument.Technical support (ts) confirmed that the current retention time was within acceptable range; therefore, there was no need for flow factor adjustment.It is not known whether hemoglobin a1c results were impacted due to the out of range retention time.There is no indication of any patient intervention or adverse health consequences due to this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOSOH HLC-723G8 ANALYZER G8
Type of Device
G8
Manufacturer (Section D)
TOSOH CORPORATION
shiba-koen first building
3-8-2 shiba
minato-ku, tokyo 105-8 623
JA  105-8623
MDR Report Key7405581
MDR Text Key105248023
Report Number8031673-2018-00276
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
PMA/PMN Number
K071132
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 09/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberG8
Device Catalogue Number021560
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA09/14/2018
Distributor Facility Aware Date08/27/2018
Device Age2 YR
Event Location Outpatient Diagnostic Facility
Date Report to Manufacturer09/14/2018
Initial Date Manufacturer Received 03/09/2018
Initial Date FDA Received04/07/2018
Supplement Dates Manufacturer Received08/27/2018
Supplement Dates FDA Received09/18/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-